Skip to content

Uterus Transplantation From Deceased Donor - Gothenburg III

Uterus Transplantation From Deceased Donor - Gothenburg III

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03581019
Enrollment
1
Registered
2018-07-10
Start date
2018-06-17
Completion date
2023-12-31
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Absolute Uterine Factor Infertility, Mrk Anomaly, Transplantation

Keywords

infertility, uterus, transplantation, MRKH

Brief summary

Deceased donor uterus transplantation will be offered to patients that have either been excluded from Gothenburg II because of donor criteria or because of early graft failure in Gothenburg I and II

Interventions

uterus transplantation from deceased donor

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Observational study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

recipient * initially included with IVF and excluded by donor issues of Gothenburg I or II * initially included and excluded by early graft failure of Gothenburg I or II * age \< 40 years * no systemic disease * no standing medication * satisfactory ovarian reserve * BMI \<35 and at BMI 30-35 waist circumference of \< 82 cm * absolute uterine factor infertility * psychological stable Inclusion criteria donor * brain death and suitable as multiorgan donor * acceptance for donation of uterus from family or previously by patient * age \<55 years * at least one normal pregnancy and childbirth * no previos malignancy * no systemic disease * no previous major surgery inn abdomen or on uterus

Design outcomes

Primary

MeasureTime frame
birth of healthy child1-5 years after transplantation

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026